Iovance Biotherapeutics Sees FY2025 Sales $250.000M-$300.000M.

Benzinga · 05/08 20:06

Iovance Biotherapeutics (NASDAQ:IOVA) sees FY2025 sales of $250.000 million-$300.000 million.